A Study of 2 Dose Levels of Anakinra (Kineret) for Chldren with Still's Disease

What we are studying

The purpose of this study is to compare the effects (good and bad) of the drug anakinra for the treatment of a rare disorder that causes swelling and pain in the joints, fever and a rash. In this study, anakinra will be compared to placebo. A placebo is a substance, like a sugar pill, that is not thought to have any effect on your disease or condition. In this study, participants will either receive the active study medication, anakinra, or placebo which is not active. Placebos are used in research studies to see if the drug being studied really does have an effect.

Who is Eligible

  • All Genders
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 2 - 17

Eligibility Criteria

  • Diagnosed with systemic juvenile idiopathic arthritis

What is involved

  • The study consist of a 12 week long double blind treatment period followed by a 4 week follow up after the last dose of study drug (active dose or placebo) is given. Each visit includes surveys; collection of vital signs; and review of physical activity and health.

Compensation

$850 in Total

Contact Information

Study Coordinator
Lauren Vannoy
Email
lvannoy@wakehealth.edu
Phone
3367167541
Principal Investigator
Alysha Taxter

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.